Evidence map›Paper›PMID 32856414›Full record

ArticleMolecular genetics & genomic medicine2020

Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.

Nguyen Dang Ton, Nguyen Duc Thuan, Ma Thi Huyen Thuong, Tran Thi Bich Ngoc, Vu Phuong Nhung, Nguyen Thi Thanh Hoa, Nguyen Hoai Nam, Hoang Thi Dung, Nhu Dinh Son, Nguyen Van Ba and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Rethinking 'rare'Journal of Parkinson's disease · 2025
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Nguyen Dang TonInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.ORCID 0000-0003-0182-8996
Nguyen Duc Thuan103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.
Ma Thi Huyen ThuongInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Tran Thi Bich NgocInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Vu Phuong NhungInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Nguyen Thi Thanh HoaInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Nguyen Hoai NamInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Hoang Thi Dung103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.
Nhu Dinh Son103 Military Hospital, Vietnam Military Medical University, Hanoi, Vietnam.
Nguyen Van BaVietnam Military Medical University, Hanoi, Vietnam.
Nguyen Duy BacVietnam Military Medical University, Hanoi, Vietnam.
Tran Ngoc TaiUniversity Medical Center HCMC, University of Medicine and Pharmacy at HCMC, Ho Chi Minh City, Vietnam.
Le Thi Kim DungVietnam Military Medical University, Hanoi, Vietnam.
Nguyen Trong HungNational Geriatric Hospital, Hanoi, Vietnam.
Nguyen Thuy DuongInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Nguyen Hai HaInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Nong Van HaiInstitute of Genome Research, Vietnam Academy of Science and Technology, Hanoi, Vietnam.ORCID 0000-0003-2939-8430
Vietnam Academy of Science and Technology · VNVietnam Military Medical University · VNUniversity Medical Center HCMC · VNVietnam National Children's Hospital · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly-onset Parkinson's disease (EOPD) refers to that of patients who have been diagnosed or had onset of motor symptoms before age 50, accounting for 4% of Parkinson's disease patients. The PRKN and PINK1 genes, both involved in a metabolic pathway, are associated with EOPD.

methodsTo identify variants associated with EOPD, coding region of PARKIN and PINK1 genes in 112 patients and 112 healthy individuals were sequenced. Multiplex ligation-dependent probe amplification kit was used to determine EOPD patients that carried mutations in PRKN and PINK1 genes. RESULTS AND

conclusionThree rare and three novel mutations in total of 14 variants of PARKIN and PINK1 were detected in the EOPD cohorts. Mutations of PRKN and PINK1 genes were found in five (4.4%) patients, which were four patients with compound heterozygous variants in the PRKN and one case with a homozygous mutation of the PINK1 gene. The novel mutations might reduce the stability of the PRKN and PINK1 protein molecules. The frequency of homozygous mutant genotype p.A340T of the PINK1 in the EOPD cohort was higher than in control (p = 0.0001, OR = 5.704), suggesting this variant might be a risk factor for EOPD. To the best of our knowledge, this is the first study of PRKN and PINK1 genes conducted on Vietnamese EOPD patients. These results might contribute to the genetic screening of EOPD in Vietnam.

Indexed as

MutationAdultAge of OnsetFemaleGene FrequencyHeterozygoteHomozygoteHumansMaleMiddle AgedParkinson DiseaseProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein LigasesVietnamparkin proteinProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein Ligasesearly-onset Parkinson's diseasePARKINPINK1Vietnamese

Identifiers

PMID32856414
PMCPMC7549612
OpenAlexW3080212276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.